PubMed:33754144 / 0-192 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/33754144","sourcedb":"PubMed","sourceid":"33754144","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/33754144","text":"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":192},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":192},"obj":"Sentence"}],"attributes":[{"subj":"T1","pred":"source","obj":"Inflammaging"},{"subj":"T1","pred":"source","obj":"Inflammaging"}]},{"project":"yangbin123xm_800_3","denotations":[{"id":"T1","span":{"begin":37,"end":55},"obj":"DP"},{"id":"T4","span":{"begin":0,"end":12},"obj":"CI"}],"attributes":[{"subj":"T1","pred":"source","obj":"yangbin123xm_800_3"},{"subj":"T4","pred":"source","obj":"yangbin123xm_800_3"}]},{"project":"chenxin_473849_800_3","denotations":[{"id":"T5","span":{"begin":0,"end":12},"obj":"CI"},{"id":"T15","span":{"begin":37,"end":55},"obj":"DP"}],"attributes":[{"subj":"T5","pred":"source","obj":"chenxin_473849_800_3"},{"subj":"T15","pred":"source","obj":"chenxin_473849_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#a0ec93","default":true},{"id":"yangbin123xm_800_3","color":"#ec93ba"},{"id":"chenxin_473849_800_3","color":"#93d5ec"}]}]}}